Note: This section contains information in English only.On Monday, shares in UK's AstraZeneca were down 2.1% after a report that the firm had approached its US rival Gilead Sciences about a potential merger with the intention to form the world's biggest drug company.
Mon, 08 Jun 2020 09:18:31 GMT
Source: Dukascopy Bank SA